InventureinInventure VCBacking Biomatter to Revolutionize Enzyme Design from the Ground UpKevin LöschAug 5Aug 5
InventureinInventure VCBacking Valo.ai to solve SaaS chaos in enterprisesBy Timo Tirkkonen and Lauri KokkilaJul 10Jul 10
InventureinInventure VCBuilding in healthcare: Insights from the founder of MedomaIn our recently published blog on healthcare, we talked about how AI is currently reshaping the industry and setting the stage for a new…Mar 27Mar 27
InventureinInventure VCBacking Reveel: The company changing tourism, one destination at a timeOur investment in ReveelFeb 7Feb 7
InventureinInventure VCThe Healthtech Renaissance: Why AI in healthcare has us thrilledThis blog kicks off our deep dive series into AI in Healthcare, presenting the current state of affairs and sharing what makes us so…Jan 31Jan 31
InventureinInventure VCLassie: From seed to series B in 2.5 yearsIn May 2021, we led the seed round of our portfolio company, Lassie. Fast-forward to November 2023, they announced their new €23 million…Dec 22, 2023Dec 22, 2023
InventureinInventure VCInventure ESG & Responsibility survey 2023 — Key TakeawaysAs the year slowly comes to an end, we want to share some key takeaways from our recently released ESG & Responsibility survey report of…Dec 13, 2023Dec 13, 2023
InventureinInventure VCWelcoming our new Investment Associate, Teodora BergNew Investment Associate alert: we’re very happy to announce we’ve added Teodora Berg to our investment team. Give her a high-five if you…Nov 27, 2023Nov 27, 2023